Fidelity® Disruptive Medicine Lylty 1
Name
As of 05/12/2023Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
Vitals
YTD Return
6.6%
1 yr return
4.6%
3 Yr Avg Return
-3.1%
5 Yr Avg Return
N/A
Net Assets
$52.3 M
Holdings in Top 10
39.7%
52 WEEK LOW AND HIGH
Expenses
OPERATING FEES
Expense Ratio 0.76%
SALES FEES
Front Load N/A
Deferred Load N/A
TRADING FEES
Turnover 44.00%
Redemption Fee N/A
Min Investment
Standard (Taxable)
$0
IRA
N/A
Fund Classification
Fund Type
Open End Mutual Fund
Name
As of 05/12/2023Price
Aum/Mkt Cap
YIELD
Exp Ratio
Watchlist
FRXLX - Profile
Distributions
- YTD Total Return 6.6%
- 3 Yr Annualized Total Return -3.1%
- 5 Yr Annualized Total Return N/A
- Capital Gain Distribution Frequency N/A
- Net Income Ratio -0.25%
- Dividend Yield 0.0%
- Dividend Distribution Frequency Annually
Fund Details
-
Legal NameFidelity® Disruptive Medicine Fund
-
Fund Family NameFidelity Investments
-
Inception DateApr 16, 2020
-
Shares OutstandingN/A
-
Share ClassOther
-
CurrencyUSD
-
Domiciled CountryUnited States
-
ManagerChristopher Lee
Fund Description
FRXLX - Performance
Return Ranking - Trailing
Period | FRXLX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 6.6% | -11.3% | 22.2% | 12.43% |
1 Yr | 4.6% | -25.3% | 34.3% | 37.87% |
3 Yr | -3.1%* | -21.1% | 15.7% | 60.00% |
5 Yr | N/A* | -14.9% | 12.1% | N/A |
10 Yr | N/A* | -6.6% | 15.9% | N/A |
* Annualized
Return Ranking - Calendar
Period | FRXLX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | -33.6% | -53.9% | 5.0% | 93.67% |
2022 | 2.8% | -22.3% | 12.3% | 27.85% |
2021 | N/A | -4.7% | 41.4% | N/A |
2020 | N/A | -10.2% | 13.1% | N/A |
2019 | N/A | -5.7% | 16.7% | N/A |
Total Return Ranking - Trailing
Period | FRXLX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
YTD | 6.6% | -50.0% | 17.9% | 9.47% |
1 Yr | 4.6% | -60.2% | 34.3% | 38.24% |
3 Yr | -3.1%* | -21.1% | 17.8% | 62.18% |
5 Yr | N/A* | -14.9% | 16.9% | N/A |
10 Yr | N/A* | -6.6% | 18.5% | N/A |
* Annualized
Total Return Ranking - Calendar
Period | FRXLX Return | Category Return Low | Category Return High | Rank in Category (%) |
---|---|---|---|---|
2023 | -33.6% | -53.9% | 5.0% | 93.67% |
2022 | 2.8% | -22.3% | 12.3% | 27.85% |
2021 | N/A | -4.7% | 41.4% | N/A |
2020 | N/A | -10.2% | 13.1% | N/A |
2019 | N/A | -5.7% | 16.7% | N/A |
NAV & Total Return History
FRXLX - Holdings
Concentration Analysis
FRXLX | Category Low | Category High | FRXLX % Rank | |
---|---|---|---|---|
Net Assets | 52.3 M | 1.02 M | 46.2 B | 78.11% |
Number of Holdings | 71 | 25 | 473 | 56.97% |
Net Assets in Top 10 | 22.2 M | 1.78 M | 21.6 B | 78.18% |
Weighting of Top 10 | 39.67% | 12.3% | 80.8% | 79.39% |
Top 10 Holdings
- Regeneron Pharmaceuticals Inc 5.69%
- Regeneron Pharmaceuticals Inc 5.69%
- Regeneron Pharmaceuticals Inc 5.69%
- Regeneron Pharmaceuticals Inc 5.69%
- Regeneron Pharmaceuticals Inc 5.69%
- Regeneron Pharmaceuticals Inc 5.69%
- Regeneron Pharmaceuticals Inc 5.69%
- Regeneron Pharmaceuticals Inc 5.69%
- Regeneron Pharmaceuticals Inc 5.69%
- Regeneron Pharmaceuticals Inc 5.69%
Asset Allocation
Weighting | Return Low | Return High | FRXLX % Rank | |
---|---|---|---|---|
Stocks | 98.52% | 85.37% | 106.13% | 50.91% |
Cash | 1.48% | -0.04% | 9.01% | 39.39% |
Preferred Stocks | 0.00% | 0.00% | 7.86% | 87.27% |
Other | 0.00% | -22.99% | 3.38% | 81.21% |
Convertible Bonds | 0.00% | 0.00% | 0.37% | 86.67% |
Bonds | 0.00% | 0.00% | 12.39% | 86.67% |
Stock Sector Breakdown
Weighting | Return Low | Return High | FRXLX % Rank | |
---|---|---|---|---|
Healthcare | 100.00% | 59.26% | 100.00% | 38.79% |
Utilities | 0.00% | 0.00% | 0.00% | 86.06% |
Technology | 0.00% | 0.00% | 22.69% | 89.09% |
Real Estate | 0.00% | 0.00% | 5.89% | 87.88% |
Industrials | 0.00% | 0.00% | 7.02% | 87.88% |
Financial Services | 0.00% | 0.00% | 1.60% | 87.88% |
Energy | 0.00% | 0.00% | 0.00% | 86.06% |
Communication Services | 0.00% | 0.00% | 9.11% | 86.06% |
Consumer Defense | 0.00% | 0.00% | 25.73% | 88.48% |
Consumer Cyclical | 0.00% | 0.00% | 1.92% | 87.88% |
Basic Materials | 0.00% | 0.00% | 7.16% | 89.70% |
Stock Geographic Breakdown
Weighting | Return Low | Return High | FRXLX % Rank | |
---|---|---|---|---|
US | 90.06% | 53.67% | 104.41% | 32.73% |
Non US | 8.46% | 0.00% | 45.40% | 62.42% |
FRXLX - Expenses
Operational Fees
FRXLX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Expense Ratio | 0.76% | 0.08% | 33.47% | 66.46% |
Management Fee | 0.75% | 0.00% | 1.25% | 65.68% |
12b-1 Fee | N/A | 0.00% | 1.00% | N/A |
Administrative Fee | N/A | 0.03% | 0.25% | N/A |
Sales Fees
FRXLX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Front Load | N/A | 0.00% | 5.75% | N/A |
Deferred Load | N/A | 1.00% | 5.00% | N/A |
Trading Fees
FRXLX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Max Redemption Fee | N/A | 1.00% | 1.00% | N/A |
Related Fees
Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.
FRXLX Fees (% of AUM) | Category Return Low | Category Return High | Rank in Category (%) | |
---|---|---|---|---|
Turnover | 44.00% | 0.00% | 238.00% | 45.14% |
FRXLX - Distributions
Dividend Yield Analysis
FRXLX | Category Low | Category High | FRXLX % Rank | |
---|---|---|---|---|
Dividend Yield | 0.00% | 0.00% | 2.34% | 88.82% |
Dividend Distribution Analysis
FRXLX | Category Low | Category High | Category Mod | |
---|---|---|---|---|
Dividend Distribution Frequency | Annually | Annually | Semi-Annually | Annually |
Net Income Ratio Analysis
FRXLX | Category Low | Category High | FRXLX % Rank | |
---|---|---|---|---|
Net Income Ratio | -0.25% | -2.54% | 1.85% | 54.94% |
Capital Gain Distribution Analysis
FRXLX | Category Low | Category High | Capital Mode | |
---|---|---|---|---|
Capital Gain Distribution Frequency | Annually | Semi-Annually | Annually |
FRXLX - Fund Manager Analysis
Managers
Christopher Lee
Start Date
Tenure
Tenure Rank
Apr 16, 2020
2.12
2.1%
Lee is portfolio manager at Fidelity. Since joining Fidelity in 2004 as an equity analyst, Lee has been following companies in the semiconductor sector. He previously served as an analyst intern for Minot Capital Management in Boston during the summer of 2003. From 1999 to 2002, he was an associate in the Technology Group for TA Associates, a private equity firm in Boston. Lee began his career at Robertson Stephens, where he served as a financial analyst in the Technology Group from 1997-1999.
Michael Kim
Start Date
Tenure
Tenure Rank
Apr 16, 2020
2.12
2.1%
Michael Kim is a quantitative analyst and portfolio manager in the Equity division at Fidelity Investments. Fidelity Investments is a leading provider of investment management, retirement planning, portfolio guidance, brokerage, benefits outsourcing, and other financial products and services to institutions, financial intermediaries, and individuals.
Camille Carlstrom
Start Date
Tenure
Tenure Rank
Apr 16, 2020
2.12
2.1%
Camille Carlstrom is a portfolio manager at Fidelity Institutional Asset Management (FIAM), an investment organization within Fidelity Investments’ asset management division that is dedicated to serving the needs of consultants and institutional investors, such as defined benefit and defined contribution plans, endowments and financial advisors. In this role, Ms. Carlstrom is the lead portfolio manager of the FIAM International Growth strategy and is in charge of asset allocation and risk control across the portfolio.
Fahim Razzaque
Start Date
Tenure
Tenure Rank
Apr 16, 2020
2.12
2.1%
Fahim Razzaque is co-manager of the fund, which he has managed since November 2019. Since joining Fidelity Investments in 2008, Mr. Razzaque has worked as a managing director of research, research analyst, and portfolio manager.
William Shanley
Start Date
Tenure
Tenure Rank
Apr 16, 2020
2.12
2.1%
William Shanley is co-manager of the fund, which he has managed since November 2019. Since joining Fidelity Investments in 2004, Mr. Shanley has worked as a managing director of research, research analyst and portfolio manager.
Charles Hebard
Start Date
Tenure
Tenure Rank
Apr 16, 2020
2.12
2.1%
Charlie Hebard is co-manager of each fund, which he has managed since April 2020. He also manages other funds. Since joining Fidelity Investments in 1999, Mr. Hebard has worked as a managing director of research and portfolio manager. Prior to joining Fidelity, Hebard was an assistant vice president for CiticorpSecurities Inc. in the Global Media and Communications division, from 1996 to 1997.
Niamh Brodie-Machura
Start Date
Tenure
Tenure Rank
Jul 31, 2020
1.83
1.8%
Timothy Codrington
Start Date
Tenure
Tenure Rank
Nov 30, 2020
1.5
1.5%
"Timothy Codrington is a Portfolio Manager at Copper Rock Capital Partners. He joined the firm in February of 2015 and is responsible for fundamental investment research, stock selection and portfolio construction across all of the firm’s investment strategies. Prior to joining Copper Rock, Tim worked at AGF Management Limited Canada where he was an Associate Portfolio Manager on the Global Equity team. In this role, he oversaw Global and Emerging Markets investments for approximately $7 billion in assets under management across three funds: a Global Core Fund, a Global Dividend Fund, and an Emerging Markets Fund. He was also responsible for fundamental research of global securities in the Consumer Staples and Cyclicals sectors. Prior to AGF, Tim was a Senior Vice President and Portfolio Manager on a variety of International and Global Investment strategies at Putnam Investments. He received his B.A. from Harvard University and is also a graduate of the Harvard Business School. He has over 15 years of fundamental research and portfolio management experience. "
Tenure Analysis
Category Low | Category High | Category Average | Category Mode |
---|---|---|---|
0.02 | 24.72 | 7.39 | 0.25 |